SWP
FBT icon

Stratos Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Stratos Wealth Partners’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$272K Sell
1,355
-35
-3% -$7.24K ﹤0.01% 1381
2025
Q4 		$287K Hold
1,390
– – ﹤0.01% 1314
2025
Q3 		$249K Sell
1,390
-231
-14% -$39.3K ﹤0.01% 1347
2025
Q2 		$262K Buy
1,621
+60
+4% +$9.56K ﹤0.01% 1194
2025
Q1 		$266K Sell
1,561
-260
-14% -$45.2K ﹤0.01% 1143
2024
Q4 		$303K Sell
1,821
-88
-5% -$15K ﹤0.01% 1143
2024
Q3 		$328K Sell
1,909
-1
-0.1% -$166 ﹤0.01% 1108
2024
Q2 		$294K Sell
1,910
-93
-5% -$14K ﹤0.01% 1095
2024
Q1 		$308K Sell
2,003
-3,443
-63% -$525K 0.01% 1088
2023
Q4 		$861K Buy
+5,446
New +$782K 0.02% 680
2022
Q1 		– Sell
-4,172
Closed -$676K – 1288
2021
Q4 		$676K Buy
+4,172
New +$675K 0.02% 702
2021
Q3 		– Sell
-5,174
Closed -$893K – 1207
2021
Q2 		$893K Sell
5,174
-1,378
-21% -$228K 0.02% 576
2021
Q1 		$1.05M Sell
6,552
-1,736
-21% -$297K 0.03% 482
2020
Q4 		$1.39M Sell
8,288
-360
-4% -$58.4K 0.04% 360
2020
Q3 		$1.36M Buy
8,648
+223
+3% +$36.5K 0.04% 323
2020
Q2 		$1.41M Buy
8,425
+3,753
+80% +$589K 0.05% 314
2020
Q1 		$613K Sell
4,672
-2,436
-34% -$347K 0.03% 461
2019
Q4 		$1.06M Buy
7,108
+541
+8% +$74.3K 0.04% 377
2019
Q3 		$813K Sell
6,567
-172
-3% -$22.9K 0.04% 425
2019
Q2 		$949K Buy
6,739
+887
+15% +$122K 0.04% 382
2019
Q1 		$883K Buy
5,852
+2,143
+58% +$308K 0.04% 396
2018
Q4 		$461K Buy
+3,709
New +$507K 0.02% 534
2018
Q3 		– Sell
-4,830
Closed -$676K – 2997
2018
Q2 		$676K Buy
4,830
+351
+8% +$48.2K 0.03% 468
2018
Q1 		$595K Buy
4,479
+78
+2% +$10.6K 0.03% 492
2017
Q4 		$548K Buy
4,401
+84
+2% +$10.4K 0.02% 499
2017
Q3 		$535K Buy
+4,317
New +$511K 0.03% 492
2017
Q1 		– Sell
-3,336
Closed -$303K – 828
2016
Q4 		$303K Sell
3,336
-659
-16% -$61.7K 0.02% 514
2016
Q3 		$398K Buy
3,995
+143
+4% +$14K 0.03% 408
2016
Q2 		$344K Buy
+3,852
New +$354K 0.03% 419

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Stratos Wealth Partners's FBT Position: Q1 2026 in Review

Stratos Wealth Partners reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.5% in Q1 2026, selling an estimated $7.24K and leaving 1,355 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Stratos Wealth Partners first reported a position in FBT in Q2 2016 and has held it in 29 quarters since. The position peaked at $1.41M in Q2 2020. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Stratos Wealth Partners held 1,355 shares of First Trust NYSE Arca Biotechnology Index Fund worth $272K as of Q1 2026.
  • Stratos Wealth Partners sold 35 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $7.24K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #1381 holding.
  • Stratos Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2016 and has held it in 29 quarters since.
  • Stratos Wealth Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.41M in Q2 2020.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.